FDA 483 - Ashton Hall - July 01, 2025

An FDA inspection of Ashton Hall, a beef cattle operation in Ewing, KY, revealed two significant observations. The firm offered a food-producing animal for interstate commerce that contained drug residues (Penicillin and Fluxiuxin) above established tolerance levels. Additionally, the firm failed to maintain complete and retained treatment records for its livestock, despite administering multiple veterinary drugs.